Latest Whitepapers
Whitepaper
Multiomic Sequencing Solutions To Revolutionize Human Disease Research
Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.
Whitepaper
Gene Therapy: A New Frontier in Disease-Modifying Therapies
This article explores major advances in disease modification for illnesses that still lack effective treatments, as well as some challenges and approaches to overcome them.
Whitepaper
Advances in Cell Therapy
This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
Whitepaper
Model Neurodegenerative Disease Traits More Closely
This whitepaper highlights how PFFs could become the breakthrough modeling platform for scientists to discover and develop the next therapeutic for neurodegenerative diseases.
Whitepaper
Enhanced Mouse Brain Cell Surface Expression – A Comparison to Enzymatic Methods
As researchers endeavor to map the architecture of the brain, many rely on tissue dissociation approaches to prepare single-cell suspensions for downstream analysis. Howev er, such conventional methods can involve enzymes and heat, which are known to induce transcriptional and proteotype changes in brain cells.
Whitepaper
Discovery of Blood-Based Biomarkers in Neurodegenerative Diseases
The SomaScan Assay is an ideal high throughput platform for identifying proteins that may be involved in disease pathology, as it offers a highly sensitive method of quantifying proteins in different biologic fluids such as serum, plasma, urine and cerebrospinal fluid.
Whitepaper
Streamline Antibody Labeling Workflows
Primary antibody labeling simplifies assays, enables multiplexing and eliminates the cross-reactivity seen with secondary antibodies – helping you to streamline your workflow, increase your flexibility and improve reproducibility.
Whitepaper
Reliable Results from Cell-Based Bioassays
While common laboratory plastics are generally regarded as inert by researchers, some commonly used products such as pipette tips and sample tubes have been reported to leach chemical compounds including oleamide, erucamide and DiHEMDA.
Whitepaper
Water Maze Testing and Alzheimer's Research
Alzheimer’s disease (AD) is the most common form of dementia, and it is also one of the most common neurodegenerative diseases. AD comes with memory impairments, and as a result many of the neurobehavioral studies done on AD involve the water maze test.
Whitepaper
The Potential of Psychedelic Medicine to Transform Mental Health Treatment
Learn about the focus of current psychedelic research efforts and where the most promising progress is being made in this exciting area of drug discovery and development.
Advertisement